Table 2.
Characteristics |
RP11-147l13.8 |
||
---|---|---|---|
Low (n = 48) | High (n = 48) | p value | |
Age, years | |||
≤60 | 27 | 23 | 0.414 |
>60 | 21 | 25 | |
Gender | |||
Female | 29 | 27 | 0.679 |
Male | 19 | 21 | |
Diabetes mellitus | |||
No | 25 | 28 | 0.538 |
Yes | 23 | 20 | |
CA 19-9 (U/mL) | |||
≤37 | 26 | 21 | 0.841 |
>37 | 19 | 24 | |
Tumor size (cm) | |||
≤2.5 | 21 | 35 | 0.004 |
>2.5 | 27 | 13 | |
Venous invasion | |||
No | 28 | 40 | p < 0.001 |
Yes | 20 | 8 | |
Grade | |||
Well-differentiated | 7 | 14 | 0.224 |
Moderately differentiated | 25 | 21 | |
Poorly differentiated | 16 | 13 | |
TNM stage | |||
I+II | 39 | 46 | 0.025 |
III+IV | 9 | 2 |
Pearson chi-square test and Fisher’s exact test. CA 19-9, carbohydrate antigen 19-9; TNM, tumor, lymph node, metastasis.